2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …

RA Byrne, X Rossello, JJ Coughlan… - … Heart Journal: Acute …, 2024 - academic.oup.com
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

2018 ESC/EACTS Guidelines on myocardial revascularization

M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

2018 ESC/EACTS Guidelines on myocardial revascularization

FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of …

B Ibanez, S James, S Agewall, MJ Antunes… - European heart …, 2018 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …

M Valgimigli, H Bueno, RA Byrne, JP Collet… - European heart …, 2018 - academic.oup.com
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …

P Urban, R Mehran, R Colleran, DJ Angiolillo… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …

JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome

K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week

T Doenst, A Haverich, P Serruys, RO Bonow… - Journal of the American …, 2019 - jacc.org
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are
considered revascularization procedures, but only CABG can prolong life in stable coronary …

Wearable and implantable devices for drug delivery: Applications and challenges

A Kar, N Ahamad, M Dewani, L Awasthi, R Patil… - Biomaterials, 2022 - Elsevier
Poor adherence to drug dosing schedule is responsible for∼ 50% of hospitalization cases.
Most patients fail to adhere to a strict dosing schedule due to invasive drug administration …

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

O Varenne, S Cook, G Sideris, S Kedev, T Cuisset… - The Lancet, 2018 - thelancet.com
Background Elderly patients regularly receive bare-metal stents (BMS) instead of drug-
eluting stents (DES) to shorten the duration of double antiplatelet therapy (DAPT). The aim of …